Abstract
EPS8.03 Impact of 12 months of elexacaftor/tezacaftor/ivacaftor on pulmonary function and exercise capacity in patients with cystic fibrosis
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
